
Dihexa angiotensin-derived reference compound supplied as 30 uniform 8 mg solid units.
Dihexa is a small angiotensin IV analogue used as a reference material in hepatocyte-growth-factor pathway research. Every PureLabs lot of Dihexa is produced under GMP-aligned synthesis controls, assayed by an independent partner laboratory using reverse-phase HPLC with mass-spectrometric confirmation, and released only above the stated purity threshold of 98.5%. The certificate of analysis is lot-specific, carries the chromatogram and MS trace for the exact vial you receive, and stays archived under reference SEQ-1122 for as long as the batch exists.
Common laboratory questions about sourcing, purity, storage and shipping of Dihexa.
Current stock assays at 98.5% by reverse-phase HPLC, confirmed by mass spectrometry at an independent laboratory. Any lot testing below the threshold is rejected rather than sold.
Yes. A lot-specific certificate of analysis including the HPLC chromatogram and MS trace accompanies every Dihexa order and remains retrievable under batch reference SEQ-1122.
Keep Dihexa sealed at 2–8 °C with its desiccant, away from light and moisture.
Orders confirmed before 15:00 UTC dispatch the same working day in insulated, tracked cold-chain packaging, subject to the import rules of the destination country.
No. PureLabs supplies this compound strictly as reference material for in-vitro and laboratory research. It is not a medicine and is not for human or veterinary consumption.